Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose for cognitive impairment in the elderly
IRCT20260625069941N1Phase 2Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of trehalose in Mild Cognitive Impairment (MCI), sponsored by Mashhad University of Medical Sciences. Started Aug 2026; status: recruiting.
02
Drugs
trehalose
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on IRCT20260625069941N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260625069941N1.